ArticleHistochemistry and cell biology2025
The protective role of vitamin E against the effects of hyperthyroidism on the rat pituitary-ovary axis.
Article in Histochemistry and cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Urolithin A-Enhanced Multi-Bioactive Formulation Mitigates Cyclophosphamide-Induced Premature Ovarian Failure Through Suppression of Oxidative-Inflammatory Stress and Preservation of Follicle Fate.Antioxidants (Basel, Switzerland) · 2026Article
- Vitamin E Protects Against Gestational Deep Vein Thrombosis: The Role of Inhibiting Endothelial Ferroptosis.Drug design, development and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the effects of an experimentally induced hyperthyroidism model on the pituitary-ovarian axis and the possible protective role of vitamin E against these adverse effects. Wistar albino rats were divided into five groups of eight animals each: control ("Cont," no any treatment); hyperthyroidism ("Hypert," L-thyroxine at 0.3 mg/kg/day); "Sham" (1 ml/day corn oil); "Hypert + vit E" (L-thyroxine (0.3 mg/kg/day and 100 mg/kg/day/1 ml vitamin E); and "Vit E" (100 mg/kg/day/1 ml vitamin E) groups. At the end of the experiment, ovarian tissues were exposed to electron microscopic and stereological analyses. Thyroid stimulating hormone (TSH), free thyroxine (FT4), follicle stimulating hormone (FSH), luteinizing hormone (LH), and superoxide dismutase (SOD) levels, as well as catalase (CAT) enzyme activity, were also determined in blood serum samples. Ovarian follicle numbers and volumes; corpus luteum and cortex volume; body weights; and TSH, FSH, and SOD levels decreased significantly in the Hypert group compared with the Cont group. However, connective tissue volume, CAT enzyme activity, and FT4 levels increased in the Hypert group compared with the Cont group. Vitamin E supplementation was observed to play a protective role on antral follicle, corpus luteum, and connective tissue volumes, CAT activity, and SOD and FSH levels. Hyperthyroidism reduces the number of ovarian follicles and may cause infertility problems. The adverse effect of hyperthyroidism on the pituitary-ovarian axis can be ameliorated by means of vitamin E, since this may have a homeostatic effect on this axis, as shown by the biochemical, histopathological, and stereological analyses in this study.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.